Your browser doesn't support javascript.
loading
Patient-reported outcomes after oesophagectomy in the multicentre LASER study.
Markar, S R; Sounderajah, V; Johar, A; Zaninotto, G; Castoro, C; Lagergren, P; Elliott, J A; Gisbertz, S S; Mariette, C; Alfieri, R; Huddy, J; Pinto, E; Scarpa, M; Klevebro, F; Sunde, B; Murphy, C F; Greene, C; Ravi, N; Piessen, G; Brenkman, H; Ruurda, J; van Hillegersberg, R; Lagarde, S M; Wijnhoven, B P; Pera, M; Roigg, J; Castro, S; Matthijsen, R; Findlay, J; Antonowicz, S; Maynard, N; McCormack, O; Ariyarathenam, A; Sanders, G; Cheong, E; Jaunoo, S; Allum, W; van Lanschot, J; Nilsson, M; Reynolds, J V; van Berge Henegouwen, M I; Hanna, G B.
Afiliación
  • Markar SR; Department Surgery and Cancer, Imperial College London, London, UK.
  • Sounderajah V; Division of Surgery, Department of Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
  • Johar A; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Zaninotto G; Department Surgery and Cancer, Imperial College London, London, UK.
  • Castoro C; Division of Surgery, Department of Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
  • Lagergren P; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Elliott JA; Department Surgery and Cancer, Imperial College London, London, UK.
  • Gisbertz SS; Unit of Surgical Oncology of the Oesophagus and Digestive Tract, Veneto Institute of Oncology, Padua, Italy.
  • Mariette C; Department Surgery and Cancer, Imperial College London, London, UK.
  • Alfieri R; Division of Surgery, Department of Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
  • Huddy J; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Pinto E; Department of Surgery, Trinity Centre for Health Sciences, St James's Hospital and Trinity College Dublin, Dublin, Ireland.
  • Scarpa M; Department of Surgery, Cancer Centre Amsterdam, Amsterdam UMC, location AMC, University of Amsterdam, Amsterdam, the Netherlands.
  • Klevebro F; Department of Digestive and Oncological Surgery, University of Lille, Claude Huriez University Hospital, F-59000 Lille, France.
  • Sunde B; Unit of Surgical Oncology of the Oesophagus and Digestive Tract, Veneto Institute of Oncology, Padua, Italy.
  • Murphy CF; Department Surgery and Cancer, Imperial College London, London, UK.
  • Greene C; Unit of Surgical Oncology of the Oesophagus and Digestive Tract, Veneto Institute of Oncology, Padua, Italy.
  • Ravi N; Unit of Surgical Oncology of the Oesophagus and Digestive Tract, Veneto Institute of Oncology, Padua, Italy.
  • Piessen G; Division of Surgery, Department of Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
  • Brenkman H; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Ruurda J; Division of Surgery, Department of Clinical Science Intervention and Technology (CLINTEC), Karolinska Institutet, Stockholm, Sweden.
  • van Hillegersberg R; Department of Upper Abdominal Diseases, Karolinska University Hospital, Stockholm, Sweden.
  • Lagarde SM; Department of Surgery, Trinity Centre for Health Sciences, St James's Hospital and Trinity College Dublin, Dublin, Ireland.
  • Wijnhoven BP; Department of Surgery, Trinity Centre for Health Sciences, St James's Hospital and Trinity College Dublin, Dublin, Ireland.
  • Pera M; Department of Surgery, Trinity Centre for Health Sciences, St James's Hospital and Trinity College Dublin, Dublin, Ireland.
  • Roigg J; Department of Digestive and Oncological Surgery, University of Lille, Claude Huriez University Hospital, F-59000 Lille, France.
  • Castro S; Department of Surgery, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Matthijsen R; Department of Surgery, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Findlay J; Department of Surgery, University Medical Centre Utrecht, Utrecht, the Netherlands.
  • Antonowicz S; Department of Surgery, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.
  • Maynard N; Department of Surgery, Erasmus MC, University Medical Centre, Rotterdam, the Netherlands.
  • McCormack O; Department of Surgery, University Hospital del Mar, Barcelona, Spain.
  • Ariyarathenam A; Department of Surgery, University Hospital del Mar, Barcelona, Spain.
  • Sanders G; Department of Surgery, University Hospital del Mar, Barcelona, Spain.
  • Cheong E; Department of Gastrointestinal Surgery, ETZ Tildburg, Tildburg, the Netherlands.
  • Jaunoo S; Oesophago-gastric Centre, Churchill Hospital, University of Oxford, Oxford, UK.
  • Allum W; Oesophago-gastric Centre, Churchill Hospital, University of Oxford, Oxford, UK.
  • van Lanschot J; Oesophago-gastric Centre, Churchill Hospital, University of Oxford, Oxford, UK.
  • Nilsson M; Department of Oesophago-Gastric Surgery, Royal Marsden Hospital, London, UK.
  • Reynolds JV; Department of Oesophago-Gastric Surgery, Plymouth Hospitals NHS Trust, Plymouth, UK.
  • van Berge Henegouwen MI; Department of Oesophago-Gastric Surgery, Plymouth Hospitals NHS Trust, Plymouth, UK.
  • Hanna GB; Department of Upper Gastrointestinal Surgery, Norfolk and Norwich Hospitals NHS Trust, Norwich, UK.
Br J Surg ; 108(9): 1090-1096, 2021 09 27.
Article en En | MEDLINE | ID: mdl-33975337
ABSTRACT

BACKGROUND:

Data on the long-term symptom burden in patients surviving oesophageal cancer surgery are scarce. The aim of this study was to identify the most prevalent symptoms and their interactions with health-related quality of life.

METHODS:

This was a cross-sectional cohort study of patients who underwent oesophageal cancer surgery in 20 European centres between 2010 and 2016. Patients had to be disease-free for at least 1 year. They were asked to complete a 28-symptom questionnaire at a single time point, at least 1 year after surgery. Principal component analysis was used to assess for clustering and association of symptoms. Risk factors associated with the development of severe symptoms were identified by multivariable logistic regression models.

RESULTS:

Of 1081 invited patients, 876 (81.0 per cent) responded. Symptoms in the preceding 6 months associated with previous surgery were experienced by 586 patients (66.9 per cent). The most common severe symptoms included reduced energy or activity tolerance (30.7 per cent), feeling of early fullness after eating (30.0 per cent), tiredness (28.7 per cent), and heartburn/acid or bile regurgitation (19.6 per cent). Clustering analysis showed that symptoms clustered into six domains lethargy, musculoskeletal pain, dumping, lower gastrointestinal symptoms, regurgitation/reflux, and swallowing/conduit problems; the latter two were the most closely associated. Surgical approach, neoadjuvant therapy, patient age, and sex were factors associated with severe symptoms.

CONCLUSION:

A long-term symptom burden is common after oesophageal cancer surgery.
Asunto(s)

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Neoplasias Esofágicas / Esofagectomía / Medición de Resultados Informados por el Paciente Tipo de estudio: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Br J Surg Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Complicaciones Posoperatorias / Neoplasias Esofágicas / Esofagectomía / Medición de Resultados Informados por el Paciente Tipo de estudio: Incidence_studies / Observational_studies / Prevalence_studies / Prognostic_studies Aspecto: Patient_preference Límite: Aged / Female / Humans / Male / Middle aged País/Región como asunto: Europa Idioma: En Revista: Br J Surg Año: 2021 Tipo del documento: Article País de afiliación: Reino Unido